The Role of the t-PA I/D and PAI-1 4G/5G Polymorphisms in African-American Adults With a Diagnosis of Myocardial Infarction or Venous Thromboembolism

This publication has 21 references indexed in Scilit:

• Gene Polymorphisms Predicting High Plasma Levels of Coagulation and Fibrinolysis Proteins
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Arterial and Venous Thrombosis Is Not Associated With the 4G/5G Polymorphism in the Promoter of the Plasminogen Activator Inhibitor Gene in a Large Cohort of US Men
  Circulation, 1997
• Plasminogen Activator Inhibitor-1 Promoter 4G/5G Genotype and Plasma Levels in Relation to a History of Myocardial Infarction in Patients Characterized by Coronary Angiography
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• A racial difference in the prevalence of the Arg506->Gln mutation
  Thrombosis Research, 1996
• Activated protein C resistance caused by Arg506Gln mutation in factor Va
  The Lancet, 1994
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Genetic Susceptibility to Death from Coronary Heart Disease in a Study of Twins
  New England Journal of Medicine, 1994
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction
  The Lancet, 1993
• An Efficient Program for Computing Conditional Maximum Likelihood Estimates and Exact Confidence Limits for a Common Odds Ratio
  Epidemiology, 1991
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987